MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2022 International Congress

    Hidden effects of COVID-19 pandemic on Parkinson’s Disease: a telemedicine survey

    V. Tommasini, C. Bertolotti, M. Catalan, P. Polverino, L. Antonutti, G. Bellavita, A. Cucca, M. Liccari, P. Manganotti (Trieste, Italy)

    Objective: The aim of this study was to report the telemedicine experience of our Movement Disorder Unit during COVID-19 pandemic and to assess the clinical…
  • 2022 International Congress

    Deep brain stimulation of the subthalamic nucleus under general vs local anesthesia

    S. Asriyants, A. Tomskiy, A. Gamaleya, A. Poddubskaya, A. Sedov, I. Pronin (Moscow, Russian Federation)

    Objective: The aim of the study was to compare outcomes of the deep brain stimulation (DBS) of the subthalamic nucleus (STN) in patients with Parkinson’s…
  • 2022 International Congress

    Methods of biochemical diagnosis early stage of Parkinson’s disaese in Uzbekistan

    B. Kurbanov (Tashkent, Uzbekistan)

    Objective: The purpose of our study was the early diagnosis of detection of Parkinson's disease using biochemical markers. Background: In recent years, due to the…
  • 2022 International Congress

    Montreal Cognitive Assessment cutoff point for cognitive impairment in Mexican subjects with PD: A neuropsychological approach

    AJ. Hernández-Medrano, GI. Cerda-Hernández, P. Bazán-Rodríguez, E. Reséndiz-Henríquez, E. Ichikawa-Escamilla, MA. Ruiz-Mafud, RA. Abundes-Corona, G. Sánchez-Dinorín, E. Lobato-Ildefonso, A. Cervantes-Arriaga, M. Rodríguez-Violante, R. Solís-Vivanco (Mexico City, Mexico)

    Objective: To determine an optimal cutoff point of the MoCA for cognitive impairment detection in Mexican persons with PD. Background: Cognitive impairment (CI) is frequent…
  • 2022 International Congress

    Levodopa Carbidopa Intestinal Gel in Patients with Deep Brain Stimulation in Parkinson’s disease- First case series from Middle-East Region

    S. Mittal, A. Aldakheel, W. Mohammed, T. Alkhairallah, B. Klassen, M. Thomas, T. Maiti, S. Wasti (Abu Dhabi, United Arab Emirates)

    Objective: The objective is to report unique and challenging cases, who had successful control of Parkinson’s disease (PD) symptoms with combination therapy of Deep Brain…
  • 2022 International Congress

    Feasibility Of An Intensive Inpatient Parkinson’s Rehabilitation Program For Moderately Advanced Parkinson’s Disease

    L. Rubin, M. Mccrossin, C. Claro, A. Persaud, A. Hernandez, D. Barreto, K. Schlosser, E. Stack, P. Fischetti, J. Yu, D. Green, L. Ptarcinski, K. Greco, G. Fequiere, C. Francavilla, P. Moondra, A. Di Rocco (Glen Cove, USA)

    Objective: To determine the feasibility in the US of a multimodal intensive inpatient Parkinson’s Rehabilitation program for patients with moderately advanced Parkinson’s disease (PD) Background:…
  • 2022 International Congress

    Efficacy of levodopa/benserazide dispersible tablet on delayed ON in Parkinson’s disease patients with motor fluctuations: a multicenter randomized open-label cross-over trial

    HJ. Chang, J. Park, S. Oh, CW. Shin, JW. Cho, JY. Lee (Seoul, Republic of Korea)

    Objective: This study aimed to assess the efficacy of levodopa/benserazide dispersible tablet on delayed ON in Parkinson’s disease (PD) patients with motor fluctuation. Background: Delayed…
  • 2022 International Congress

    The clinical challenge of an unilateral abnormal uptake in datscan

    C. Silva, F. Barros, F. Matias, CM. Machado, FM. Moreira, M. Cunha, A. Morgadinho (Coimbra, Portugal)

    Objective: Characterize patients with unilateral abnormal uptake in DaTscan. Background: Presynaptic dopamine transporter (DaT) single-photon emission computed tomography (SPECT) imaging is the most used imaging…
  • 2022 International Congress

    Burden of COVID-19 among patients with Parkinson’s disease and associated clinical outcomes: Evidence from a meta-analysis

    S. Hussain (Brno, Czech Republic)

    Objective: To understand the burden of covid-19 among patients with Parkinson’s disease and associated clinical outcomes. Background: COVID-19 has affected millions of patients around the…
  • 2022 International Congress

    Bullous skin lesions following introduction of safinamide in a woman with Parkinson’s disease

    L. Lachance, P. Huot (Montreal, Canada)

    Objective: To present the case of a woman with Parkinson’s disease (PD) who developed pemphigoid-like skin lesions after being started on safinamide therapy. Background: Safinamide…
  • « Previous Page
  • 1
  • …
  • 420
  • 421
  • 422
  • 423
  • 424
  • …
  • 553
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley